Task: Answer the multiple-choice question.
Question: Which drug exhibits a -19.186% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) Cc1nc2ccccc2n1CC(=O)NC1CCCC1
(b) CSc1nc(SCC(=O)NCc2ccco2)c2c3c(sc2n1)COC(C)(C)C3
Answer: b. CSc1nc(SCC(=O)NCc2ccco2)c2c3c(sc2n1)COC(C)(C)C3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSc1nc(SCC(=O)NCc2ccco2)c2c3c(sc2n1)COC(C)(C)C3
CSc1nc(SCC(=O)NCc2ccco2)c2c3c(sc2n1)COC(C)(C)C3
2-[(12,12-dimethyl-5-methylsulfanyl-11-oxa-8-thia-4,6-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5-tetraen-3-yl)sulfanyl]-N-(furan-2-ylmethyl)acetamide